Labcorp Holdings Inc.

US$366.57As of Sun 8 Nov 2026, 12:00 UTC
NYSE:LHHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 13.61%
Div yield 0.79%
ROE 11.44%
Diagnostics & Research
Beta (5Y) 0.83
PE TTM 30.10
TSR TTM 45.80%
Mkt cap US$29.77B
ROIC 8.71%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$402
9.73%
(96.94%)
Hold 8|9|1|1|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
4.40
4.25
4.46
4.81
4.91%
2.19%
7.21%
17.49%
Revenue$B
1.420
1.478
1.460
1.516
7.30%
10.81%
8.61%
12.75%
Peers (US$29.77B)
Cap (US$)
PE
32.23B
36.58x
28.12B
25.47x
34.25B
37.31x
Capital
TTM
5Y
10Y
Leveragex
2.055
(0.386)
(0.367)
EBIT/Intx
5.724
0.128
0.129
Own earn%
43.86
78.20
78.37
Sh yield%
13.83
50.33
45.08
Owners
Insiders/Inst%
11.15
24.69
Short interest%
2.03
SBC / revenue%
4.70
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
13–18
$1 testx
0.0
Incr. ROIC%
5